What is Vectorious?
Vectorious Medical Technologies is at the forefront of cardiovascular innovation, dedicated to creating sophisticated implantable sensing devices. These technologies are designed to offer continuous, real-time monitoring of cardiac function, thereby enabling healthcare providers to deliver more personalized and proactive treatment strategies for individuals managing chronic heart failure. The company's focus on data-driven insights aims to revolutionize the approach to cardiovascular disease management.
How much funding has Vectorious raised?
Vectorious has raised a total of $5M across 1 funding round:
Private Equity
$5M
Private Equity (2015): $5M with participation from RAD BioMed and Global Cardiovascular Innovation Center
Key Investors in Vectorious
RAD BioMed
RAD BioMed is the investment arm of the RAD Bynet group, focusing on early-stage ventures in Israel, particularly in the MedTech, HiTech, Health, Technology, and Energy sectors. The company seeks out disruptive solutions to real-world challenges and offers long-term support to entrepreneurs through its multidisciplinary capabilities.
Global Cardiovascular Innovation Center
The Global Cardiovascular Innovation Center (GCIC) is an entity dedicated to fostering advancements in cardiovascular health through strategic investments and support for innovative technologies in the field.
What's next for Vectorious?
With its recent major strategic investment, Vectorious is poised to accelerate the development and commercialization of its groundbreaking implantable sensing technologies. This capital infusion is expected to fuel further research and development, expand clinical trials, and scale manufacturing capabilities. The company's trajectory suggests a strong emphasis on market penetration and establishing its solutions as a standard of care in heart failure treatment, positioning it for significant growth in the MedTech sector.
See full Vectorious company page
